4baa22c8 7b88 44cf A6c0 7def799cc58b 01
Arsenic Trioxide Injection
Product Images NDC 50742-438
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Arsenic Trioxide (NDC 50742-438). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Ingenus Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
4baa22c8 7b88 44cf A6c0 7def799cc58b 02
4baa22c8 7b88 44cf A6c0 7def799cc58b 03
This is a description of a sterile and non-pyrogenic solution contained in vials. Each vial contains 10 mg of Ho 50742_ and 12 mg of Sodium Hydroxide. The pH of the solution is adjusted to 8 with Sodium Hydroxide and Hydrochloric Acid. The solution is meant for intravenous use only and does not contain any preservatives. The container closure does not contain natural rubber latex. It is manufactured by Ingenus Pharmaceuticals in Switzerland. Dosage and usage instructions can be found in the enclosed prescribing information. The solution should be stored at 20°C to 25°C with excursions permitted to 30°C to 86°F. Caution is advised as this solution is a cytotoxic agent and should not be frozen.*
4baa22c8 7b88 44cf A6c0 7def799cc58b 04
This appears to be a medication label for Arsenic Trioxide Injection, with information about its concentration and recommended method of administration. The label also includes warnings about the medication being a cytotoxic agent and instructions for handling the single-dose vial.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
